|
Aug 5
|
Summit Hotel Properties (INN) Q2 FFO Top Estimates
|
|
Aug 5
|
SUMMIT HOTEL PROPERTIES REPORTS SECOND QUARTER 2025 RESULTS
|
|
Aug 1
|
SUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2025 DIVIDENDS
|
|
Jul 23
|
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
|
|
Jul 3
|
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
|
|
Jun 20
|
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
|
|
Jun 13
|
Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach
|
|
May 28
|
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update
|
|
Apr 30
|
Summit Hotel Properties (INN) Beats Q1 FFO Estimates
|
|
Apr 30
|
Summit Hotel Properties: Q1 Earnings Snapshot
|
|
Apr 30
|
SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS
|
|
Apr 29
|
INN or OHI: Which Is the Better Value Stock Right Now?
|
|
Apr 24
|
SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS
|
|
Mar 14
|
INN or NHI: Which Is the Better Value Stock Right Now?
|
|
Feb 24
|
Summit Hotel Properties: Q4 Earnings Snapshot
|
|
Feb 24
|
SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
|
|
Feb 20
|
Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders
|
|
Feb 19
|
Park Hotels & Resorts (PK) Q4 FFO Miss Estimates
|
|
Feb 16
|
Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts
|
|
Feb 10
|
Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis
|